Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Lumosa Therapeutics and CHI Memorial announce new study for acute stroke 2024-02-02 22:22
First Human Subject Enrolled in Lumosa Therapeutics' Phase 1 Trial for LT3001, a New Drug Molecule for Acute Ischemic Stroke 2017-08-01 09:46
1